Introduction
Hepatocellular carcinoma (HCC) is one of the most prevalent and intractable of human cancers, causing as many as half a million deaths per year worldwide (Parkin et al., 2001) . Chronic inflammation due to infection to hepatitis B or C viruses (HBV or HCV) is considered to be a major causative factor for development of HCC. Although recent medical advances have made great progress in diagnosis, many patients with HCCs are not diagnosed until the disease has reached an advanced stage. In addition, most HCC patients cannot be cured by surgical resection because they suffer from severe liver dysfunction and/or their tumors are widespread. Therefore prognosis of patients with HCC remains poor. It is a pressing concern to identify sensitive tumor markers, develop novel effective chemotherapeutic drugs, and discover preventive strategies.
Although the underlying etiology of HCC has been rather well characterized, the molecular mechanisms of hepatocarcinogenesis are still not well understood. Accumulating evidence suggests that multiple processes involving genetic and epigenetic alterations in a number of genes underlie hepatocarcinogenesis. Several growth factors including transforming growth factor-a (TGF-a) (Grisham, 2001 ) and insulin-like growth factor-2 (IGF-2) have been implicated in development of HCC. Altered expression of E-cadherin, MMP-1 and -7, MT1-MMP, gankyrin, SMYD3, WDRPUH, and PEG10 also appears to be associated with the development and/or progression of the disease (Feitelson et al., 2002; Hamamoto et al., 2004; Silva et al., 2005) . Tumorsuppressor genes such as p53 and AXIN1 can also play crucial roles in hepatocarcinogenesis (Tanaka et al., 1993; Satoh et al., 2000) . However, in spite of this growing body of genetic knowledge, no effective drugs are available at present for treatment of HCCs.
In order to gain further insight into the mechanisms underlying hepatocarcinogenesis and to develop novel therapeutic approaches to liver cancer, we earlier analysed gene-expression profiles on cDNA microarrays representing 23 040 genes, and identified 165 transcripts that were upregulated in HCC (Okabe et al., 2001) . In the present study we focused on one of them, a gene (later termed transcription-involved protein upregulated in HCC (TIPUH1)) that would encode a novel Kruppeltype zinc-finger protein. We found that TIPUH1 exerts oncogenic activity, and that its overexpression confers anchorage-independent growth of NIH3T3 cells. Furthermore, suppression of TIPUH1 retarded the growth of HCC cells in culture. Taken together, overexpressed TIPUH1 is involved in the proliferation and/or survival of cancer cells. Analysis of the molecular entities that immunoprecipitated with TIPUH1 identified four TIPUH1-interacting proteins, TIF1b, hnRNPU, hnRNPF, and Nucleolin. Our findings should contribute to a better understanding of HCC and to development of novel anti-HCC drugs that would specifically target TIPUH1.
Results

Identification of a novel human gene upregulated in hepatocellular carcinoma
Using a genomewide cDNA microarray containing 23 040 genes, we previously analysed expression profiles of 20 HCCs, and identified a number of genes showing altered expression between cancer tissues and corresponding noncancerous tissues (Okabe et al., 2001) . Among 165 genes that were frequently upregulated in the HCCs, we focused on a novel gene with an in-house accession name of C6242, as it was overexpressed in the majority of those tumors. The gene corresponded to an EST archived as Hs.454685, and was annotated as LOC115509 in the UniGene database of the National Center for Biotechnology Information. Semiquantitative reverse transcription-polymerase chain reaction (RT-PCR) corroborated its elevated expression in seven of 10 additional HCCs compared to corresponding noncancerous liver tissues (Figure 1a) . Moreover, its expression was augmented in all seven hepatoma cell lines examined (Figure 1b ). Our microarray data had shown that this gene was not upregulated in breast, colon, bladder or prostate cancers (data not shown).
Expression, isolation, and characterization of the novel gene Multiple-tissue Northern blotting using the C6242 cDNA as a probe revealed abundant expression of a 2.7-kb transcript specifically in the testis and placenta, but this transcript was not detected in any of the 14 other tissues examined ( Figure 1c) (Figure 1d ). This structure is typical of members of the single largest class of transcription factors within the human genome. Therefore, we termed this gene as TIPUH1. A search for amino-acid homologies in public databases identified a mouse protein (accession number: BC052084.1) and a rat protein (accession number: NM_173330.1), each of which was 83% identical to TIPUH1. These mammalian homologues were unnamed or hypothetical proteins with unknown functions.
Subcellular localization of TIPUH1
We prepared plasmids expressing FLAG-tagged TI-PUH1 and transiently transfected them into SNU475 and HepG2 hepatoma cells. Immunoblot analysis using extracts from HEK293 cells transfected with the plasmid showed a 56-kDa band corresponding to the tagged TIPUH1 protein (Figure 2a ). Immunocytochemical staining of the SNU475 and HepG2 cells and fluorescent microscopy revealed that the tagged TIPUH1 protein was present in the nuclei ( Figure 2b ). The PSORT II program consistently predicted subcellular localization of TIPUH1 protein in the nucleus.
Function of TIPUH1 on cell growth
To investigate the effect of TIPUH1 on cell growth, we established NIH3T3 cells expressing TIPUH1 stably (NIH3T3-TIPUH1 cells), and performed a colonyformation assay in soft agar ( Figure 3a ). The growth of NIH3T3-TIPUH1 cells was similar to that of controls (NIH3T3-mock cells) when they were maintained in normal culture media. Notably, NIH3T3-TIPUH1 cells formed colonies in soft agar, whereas NIH3T3-mock cells produced no colonies (Figure 3a ). This observation was confirmed by three independent experiments. These data suggest that TIPUH1 transforms NIH3T3 cells and confers anchorage-independent cell growth.
To test whether elevated expression of TIPUH1 may play a crucial role in the proliferation of HCC cells, we prepared plasmids expressing four kinds of siRNA to TIPUH1 and transfected them, together with a neomycinresistance gene, into HepG2 cells that expressed TIPUH1 abundantly. As shown in Figure 3b , plasmids expressing siRNA-02 most effectively suppressed TI-PUH1 expression compared with mock (psiU6BX) or those expressing siRNA to EGFP (psiU6BX-EGFP), whereas others showed a mild gene-silencing effect, or none. We subsequently tested whether suppression of TIPUH1 affected cell growth and found that transfection of siRNA-02 into HepG2 cells reduced their viability when compared with cells transfected with (Figure 3b ). On the other hand, siRNAs-01, -03, and -04 brought about mild decreases in the numbers of surviving cells, compared with siRNA-02. We also investigated the effect of siRNA-02 on three additional HCC cell lines (Huh7, Alexander, and SNU449) and obtained similar results (Figure 3c-e) , indicating that suppressed expression of TIPUH1 was associated with a decrease in cell viability, either as a consequence of reduced cell growth or induction of apoptosis. These data suggested that TIPUH1 might play an essential role in proliferation and/or survival of HCC cells.
Identification of TIPUH1-interacting proteins
To investigate the biological function of TIPUH1 we searched for proteins that would interact with it by means of immunoprecipitation (IP) and mass spectrometric (MS) assays. We transfected HEK293 cells with plasmids expressing FLAG-tagged TIPUH1, empty vector (mock), or unrelated FLAG-tagged protein of 70 kDa (WDRPUH). After incubating the cells, we immunoprecipitated proteins from lysates using an anti-FLAG antibody conjugated with agarose beads. Comparison of the bands of the immunoprecipitants on sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis (PAGE) identified at least four bands, corresponding to proteins of 120, 100, 75, and 53 kDa, which were immunoprecipitated specifically from lysates of cells transfected with TIPUH1 (data not shown). These bands were excised and subsequently analysed by matrix-assisted laser desorption/ionization mass spectrometry. The 120-kDa protein corresponded to hnRNPU; the 100-kDa protein to a transcriptional corepressor, TIF1b (also termed Kap-1), the 75-kDa protein to nucleolin, and the 53-kDa protein to hnRNPF.
Using anti-FLAG antibody we immunoprecipitated extracts from cells transfected with p3xFLAG-TIPUH1 or mock vector, and confirmed that hnRNPU was coimmunoprecipitated from cells with TIPUH1, but not from cells containing mock vector (Figure 4a ). Conversely, IP with anti-hnRNPU antibody co-immunoprecipitated FLAG-tagged TIPUH1 from cells transfected with p3xFLAG-TIPUH1 but not those with mock Although further studies are needed to prove the interaction between endogenous TIPUH1 and these proteins, the data provided here should help for the clarification of the biological function of TIPUH1, and the identification of novel therapeutic strategies to HCC.
Discussion
Although we have shown that TIPUH1 expression is elevated in the majority of hepatocarcinomas, the mechanism(s) of its augmentation remains unresolved. Several studies have reported gain or amplification of chromosome 16p, where TIPUH1 is located (Wilkens et al., 2001; Kim et al., 2003; Raidl et al., 2004) . Therefore genetic amplification of TIPUH1 may be involved in the enhancement. Alternatively, other mechanism(s), such as transcriptional activation or increased mRNA stability, may play a role for the upregulation. TIPUH1 encodes a putative protein of 500 amino acids (aa) that contains a KRAB domain at the N-terminus and Cys2-His2-type zinc-fingers in tandem. Kruppel-associated box/Cys2-His2 zinc-finger proteins (KZFP) constitute the single largest class of potential regulators of gene expression (Mark et al., 1999) . The KRAB domain is a conserved motif at the N-terminus of a large number of zinc-finger proteins, comprising a 75-amino-acid stretch that can be divided into the KRAB-A domain, a 45-aa-long minimal repression module, and the KRAB-B domain (Witzgall et al., 1994) . TIPUH1 protein contains only the KRAB-A domain that, as in other KZFPs, is located in its N-terminal region. The basic structural unit of the Kruppel-type zinc-finger is a conserved peptide of 28 aa, which is often repeated (Looman et al., 2002) . As TIPUH1 consists of only one KRAB domain and 12 Kruppel-type zinc-finger domains, it appears to be a novel member of the KZFP family.
Kruppel-associated box-containing proteins function as transcriptional repressors when tethered to template DNAs through their DNA-binding domains (Witzgall et al., 1994; Collins et al., 2001; Looman et al., 2002) . This transcriptional silencing is thought to be mediate via interaction of the KRAB box with the ubiquitous corepressor TIF1b (Nielsen et al., 1999; Collins et al., 2001) . TIF1b, also named KAP-1 or KRIP-1, can interact with numerous KRAB domains to enhance KRAB-mediated repression and to silence transcription when it is directly bound to DNA (Collins et al., 2001) . Experimental evidence suggests that this silencing activity results from recruitment of a histone deacetylase complex (Underhill et al., 2000) and/or HP-1 proteins that represent chromatin constituents associated with silencing of euchromatic genes (Nielsen et al., 1999; Collins et al., 2001) . TIF1b can use its plant homeodomain and bromo-domains to link KZFPs to Mi-2a Involvement of TIPUH1 in HCC FP Silva et al and other components of the nucleosome-remodeling and deacetylase complex (Schultz et al., 2001) . Our identification of TIF1b as one of the TIPUH1-binding proteins fits well with that notion. In addition, KRABcontaining proteins could bind to promoters RNA polymerase I, II, and III to repress their transcriptional activity, and might affect splicing of RNA as a posttranscriptional mechanism (Urrutia, 2003) . Therefore, by forming a complex with TIF1b, TIPUH1 might repress transcription by way of chromatin remodeling through histone modification, by inhibiting RNA polymerase activities, and/or by reducing the stability of RNA. Along with elevated TIPUH1 expression, our microarray data showed that TIF1b was also significantly upregulated in the majority of the HCC samples analysed (data not shown); this observation implied that enhancement of both TIPUH1 and TIF1b in HCC cells may repress expression of genes associated with apoptosis, cell cycle arrest, or growth suppression.
We also documented interaction of TIPUH1 with hnRNPU, hnRNPF, and nucleolin, all of which are involved in mRNA or rRNA processing. hnRNP proteins package nascent pre-mRNA as it is transcribed in vivo, and a discrete hnRNP particle is constituted from more than 20 hnRNP proteins (Reed and Magni, 2001) . Those proteins are responsible for appropriate packaging of RNAs that must be retained in the nucleus, such as RNAs with introns, or mutant RNAs that are unable to enter the spliceosome assembly pathway (Reed and Magni, 2001) . They are involved not only in pre-mRNA processing, transport, localization, stability, and translation of mRNA, but also in alternative splicing (Caceres and Kornblihtt, 2002) and regulation of telomerase (Ford et al., 2002) . In addition, hnRNP-U associates with a transcription factor, Yesassociated protein (YAP), to modulate its transactivation of Bax (Howell et al., 2000) . Future studies may help to clarify whether elevated expression of TIPUH1 reflects augmented generation and subsequent processing of mRNA and/or rRNA in cancer cells, or a deregulation of RNA-engineering that results in production of aberrant transcripts.
Recent studies have disclosed that KZFPs play important roles during cell differentiation and development, cell proliferation, apoptosis, and neoplastic transformation (Urrutia, 2003) . Some KZFP proteins are also implicated in cancer; for example, human Kruppel-related gene 1 (HKR1) is highly expressed in lung cancers, particularly tumors treated with cisplatin (Oguri et al., 1998) . TIPUH1 could be involved in hepatocarcinogenesis either through a transcriptionalrepressive mechanism or through modification of mRNA splicing, by associating with its binding proteins.
As it was expressed exclusively in the testis and placenta among 16 normal tissues and its expression was enhanced in the great majority of HCC cases we examined, TIPUH1 appears to be a novel cancer-testis antigen. Therefore, immunotherapies targeting TIPUH1 could be explored as a good therapeutic option. In fact, the suppression of TIPUH1 expression by a genespecific siRNA, resulting in growth inhibition, indicated that inhibitors of TIPUH1 should be effective anti-HCC drugs; moreover, they should be relatively safe because expression of TIPUH1 is weak or absent in normal adult human tissues except for the testis and placenta. We identified four proteins that interact with the gene product: transcriptional corepressor TIF1b and three proteins involved in RNA engineering, hnRNPU, hnRNPF, and nucleolin. The data suggest that TIPUH1 is a key factor for proliferation of HCC cells, through regulation of transcription and/or mRNA processing. The four TIPUH-interacting proteins we identified may facilitate screening for inhibitors of TIPUH1.
Materials and methods
Cell lines
Human embryonic kidney 293 (HEK293) cells were obtained from IWAKI; human hepatoma cell lines Alexander and HepG2, and mouse a fibroblast cell line NIH3T3, were from the American Type Culture Collection (ATCC). Another human hepatoma cell line, Huh7, was obtained from the Japanese Collection of Research Bioresources (JCRB), whereas SNU398, SNU423, SNU449, and SNU475 were obtained from the Korean cell-line bank. All cell lines were grown in monolayers in appropriate media: Dulbecco's modified Eagle's medium (DMEM) for Alexander, Huh7, HepG2, and HEK293, and RPMI1640 for SNU398, SNU423, SNU449, and SNU475. All media were supplemented with 10% fetal bovine serum and 1% antibiotic/antimycotic solution (Sigma, St. Louis, MO, USA), and cells were maintained at 371C in humidified air containing 5% CO 2 .
Semiquantitative reverse transcription-polymerase chain reaction Semiquantitative RT-PCR was carried out as described elsewhere (Silva et al., 2005) . Amplification proceeded for 4 min at 941C for denaturing, followed by 35 cycles for TIPUH1 and 20 for GAPDH, at 941C for 30 s, 561C for 30 s, and 721C for 45 s, in the GeneAmp PCR system 9700 (PerkinElmer, Foster City, CA, USA). Primer sequences for GAPDH were: forward, 5 0 -ACAACAGCCTCAAGATCATCAG-3 0 and reverse, 5 0 -GGTCCACCACTGACACGTTG-3 0 ; and for TIPUH1, forward, 5 0 -GTGGCACTGTGGTGTTACCTTAT-3 0 and reverse 5 0 -CCTCTAAACCTTTGCCTACGACT-3 0 .
Northern blot analysis
Human multiple-tissue blots (Clontech, Palo Alto, CA, USA) were hybridized with a 32 P-labeled cDNA fragment of TIPUH1). Prehybridization, hybridization, and washing were performed according to the supplier's recommendations. The blots were autoradiographed with intensifying screens at À801C for 120 h.
5
0 rapid amplification of cDNA ends 5 0 rapid amplification of cDNA ends experiments were carried out using a Marathon cDNA amplification kit (Clontech) according to the manufacturer's instructions. For the amplification of the 5 0 part of TIPUH1 cDNA, we used a genespecific reverse primer (5 0 -TAGATTCTGGGCGCACTTGT GGCTCTCC-3 0 ) and the AP-1 primer supplied in the kit. The cDNA template was synthesized from human testis mRNA (Clontech).
Construction of plasmids expressing TIPUH1
The entire coding region of TIPUH1 was amplified by RT-PCR using gene-specific primers 5 0 -GGGGTACCACCATGG CGCCACCTTCG-3 0 and 5 0 -CGGAATTCATGGGCGTTGC CCCTCTGACTGG-3 0 . The PCR products were cloned into an appropriate cloning site of pcDNA3.1 (Invitrogen, Carlsbad, CA, USA), p3xFLAG-CMV-10 (Sigma), or pcDNA3.1myc/His (Invitrogen) vector.
Immunoprecipitation and Western blot analysis HEK293 cells, which do not express TIPUH1, were transfected with p3xFLAG-TIPUH1 or mock vector. Extraction of protein, IP, and Western blot analysis were performed as described in our previous report (Silva et al., 2005) . Anti-FLAG M2 antibody conjugated with agarose (Sigma) was used for IP, and mouse anti-FLAG M2 (Sigma) antibody, anti-TIF1b, anti-hnRNPF, anti-hnRNPU, and anti-nucleolin (Santa Cruz Biotechnology, Santa Cruz, CA, USA) were used for Western blot analyses. Horseradish peroxidase-conjugated goat anti-mouse immunoglobulin G (IgG) (Amersham Pharmacia Biotechnologies, Little Chalfont, UK) or donkey antigoat IgG (Santa Cruz) served as the secondary antibody for the ECL Detection System (Amersham).
Immunocytochemical staining SNU475 and HepG2 cells transfected with p3xFLAG-TIPUH1 or p3xFLAG-mock (empty) plasmids were fixed with PBS containing 4% paraformaldehyde for 15 min. Immunocytochemical staining using mouse anti-FLAG antibody (Sigma) was carried out as described elsewhere (Satoh et al., 2000) . Nuclei were counter-stained with 4 0 ,6 0 -diamidine-2 0 -phenylindole dihydrochloride (DAPI).
Colony-formation assay
We established NIH3T3 cells expressing TIPUH1 stably (NIH3T3-TIPUH1), and performed colony-formation assay in soft agar. Briefly, NIH3T3-TIPUH1 cells and control NIH3T3-mock cells were suspended in DMEM containing 10% FCS and 0.4% low melting temperature agarose (Cambrex Bio Science, Baltimore, USA), and plated onto solidified 0.53% agarose containing DMEM with 10% FCS in a 10 cm dish at a density of 1 Â 10 4 cells/dish. Number of colonies was counted 3 weeks after the plating.
Gene-silencing effect of TIPUH1 siRNAs Plasmids expressing TIPUH1 siRNAs were prepared by cloning double-stranded oligonucleotides into the psiU6BX vector as described elsewhere (Shimokawa et al., 2003 0 . psiU6BX-TIPUH1, psiU6BX-EGFP (Shimokawa et al., 2003) and psiU6BX-mock (empty) plasmids were transfected into HepG2, Huh7, SNU449, and Alexander cells, using FuGENE6 reagent or Nucleofector according to the suppliers' recommendations (Roche Diagnostics, Mannheim, Germany and Amaxa, Cologne, Germany). Total RNA was extracted from the cells 48 h after transfection. Silencing of the TIPUH1 gene by the specific constructs was confirmed by RT-PCR. Cell viability was measured using Cell-counting kit-8 (DOJINDO, Kumamoto, Japan) 7 days after transfection according to the supplier's recommendations. The data were subjected to analysis of variance and the Student's t-test.
Matrix-assisted laser desorption/ionization mass spectrometry Proteins immunoprecipitated with anti-FLAG antibody from cells transfected with p3xFLAG-TIPUH1, mock, or with p3xFLAG-WDRPUH expressing an unrelated protein (Silva et al., 2005) were separated by SDS-PAGE. Detection of specific bands and subsequent analysis of the protein by matrix-assisted laser desorption/ionization mass spectrometry was performed as described previously (Silva et al., 2005) .
